Complete Filing Data
Petros Pharmaceuticals, Inc. reported Stockholders Equity of $16.70 million for FY2022.
All values from 10-K, 20-F, and 10-Q filings on SEC EDGAR, organized by financial statement. Scroll each table horizontally for the full history. Blank cells mean Petros Pharmaceuticals, Inc. did not report that metric for that period in XBRL — often because accounting standards changed which tag a company files under (for example, most companies moved revenue to the ASC-606 tag in 2018), so a metric may continue in a different row. Rows marked * merge those successor tags into one continuous series, preferring the audited value from the newest-standard tag where periods overlap.
Income Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Net Income * | -$14.3M | -$8.2M | -$20.0M | -$9.0M | -$20.6M |
| Selling General And Administrative Expense | $8.7M | $9.3M | $12.2M | $15.6M | $15.7M |
| Operating Income Loss | -$17.7M | -$13.6M | -$19.9M | -$18.0M | -$17.3M |
| Operating Expenses | $21.6M | $17.8M | $23.6M | $24.3M | $22.8M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$14.3M | -$8.2M | -$20.0M | -$9.0M | -$22.0M |
| Gross Profit | $3.9M | $4.2M | $3.7M | $6.2M | $5.5M |
| Cost Of Goods And Services Sold | $1.2M | $1.6M | $2.3M | $1.6M | $4.0M |
| Research And Development Expense | $2.6M | $2.4M | $1.7M | $1.8M | $459.6K |
| Interest Income Expense Net | $371.8K | $515.3K | $14.2K | ||
| Interest Expense On Promissory Notes | $536.1K | $596.0K | |||
| Other Nonoperating Income Expense | $3.4M | $5.5M | -$121.8K | ||
| Revenue From Contract With Customers Excluding Assessed Taxes | $5.1M | $5.8M | $6.0M | ||
| Net Income Loss Available To Common Stockholders Basic | -$26.8M | -$13.8M | -$20.0M | ||
| Revenue From Contract With Customer Excluding Assessed Tax | $6.0M | $7.8M | $9.6M | ||
| Income Tax Expense Benefit | $0.00 | $0.00 | $0.00 | -$1.4M | |
| Increase Decrease Of Deferred Revenue | -$117.2K | -$164.1K | $211.0K | ||
| Interest Expense Senior Debt | $368.7K | $1.3M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net Income * | -$922.7K | $5.4M | -$2.3M | -$2.2M | -$662.0K | -$2.2M | -$4.5M | -$2.5M | -$1.4M | -$13.8M | -$1.8M | -$174.2K | -$1.7M | -$2.1M | $3.0M | -$3.3M | -$5.8M | -$6.1M |
| Selling General And Administrative Expense | $990.7K | $1.8M | $1.5M | $1.2M | $1.3M | $1.5M | $2.0M | $2.2M | $2.1M | $2.2M | $3.2M | $3.9M | $3.4M | $4.1M | $3.9M | $3.1M | $4.1M | $4.8M |
| Operating Income Loss | -$990.7K | -$1.8M | -$1.5M | -$1.2M | -$1.3M | -$1.5M | -$4.8M | -$2.5M | -$1.3M | -$13.7M | -$1.7M | -$481.2K | -$3.6M | -$4.3M | -$2.2M | -$2.3M | -$5.0M | -$5.6M |
| Operating Expenses | $990.7K | $1.8M | $1.5M | $1.2M | $1.3M | $1.5M | $6.1M | $3.9M | $3.3M | $11.9M | $5.2M | $2.5M | $5.4M | $6.3M | $5.6M | $4.8M | $5.9M | $6.6M |
| Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest | -$922.7K | -$2.0M | -$1.2M | -$919.5K | $384.3K | $382.9K | -$4.5M | -$2.5M | -$1.4M | -$13.8M | -$1.8M | -$1.7M | -$2.1M | $3.0M | -$3.3M | -$5.8M | -$6.1M | |
| Gross Profit | $1.3M | $1.1M | $1.1M | $1.3M | $1.5M | $2.0M | -$1.7M | $3.5M | $2.0M | $1.8M | $2.1M | $3.4M | $2.5M | $834.3K | $1.0M | |||
| Cost Of Goods And Services Sold | $287.0K | $329.1K | $331.8K | $408.5K | $513.9K | $550.7K | $286.5K | $649.2K | $472.3K | $319.2K | $393.3K | $643.4K | $981.9K | $539.2K | $784.0K | |||
| Research And Development Expense | $588.4K | $368.8K | $1.6M | $389.1K | $866.6K | $319.1K | $735.9K | $421.2K | $405.4K | $280.6K | $500.0K | $19.2K | $36.8K | $131.6K | $139.4K | |||
| Interest Income Expense Net | $67.0K | $88.8K | $47.8K | $75.8K | $119.4K | $151.8K | $168.5K | $52.9K | $66.3K | |||||||||
| Interest Expense On Promissory Notes | $158.7K | $114.5K | $120.2K | $131.4K | $136.8K | $142.2K | $147.7K | $150.4K | $153.0K | |||||||||
| Other Nonoperating Income Expense | $68.0K | -$240.5K | $258.8K | $277.8K | $1.7M | $1.9M | $257.1K | -$83.9K | -$75.9K | |||||||||
| Revenue From Contract With Customers Excluding Assessed Taxes | $1.6M | $1.4M | $1.4M | $1.7M | $2.0M | $2.5M | -$1.5M | |||||||||||
| Net Income Loss Available To Common Stockholders Basic | -$5.2M | -$2.7M | -$8.0M | -$6.0M | -$1.4M | -$13.8M | ||||||||||||
| Revenue From Contract With Customer Excluding Assessed Tax | $2.0M | $2.5M | $4.2M | $2.5M | $2.1M | $2.5M | $4.1M | $3.5M | $1.4M | $1.8M | ||||||||
| Income Tax Expense Benefit | $10.5K | $2.3K | $6.7K | -$6.1K | -$13.8K | -$30.0K | ||||||||||||
| Increase Decrease Of Deferred Revenue | -$117.2K | -$260.4K | ||||||||||||||||
| Interest Expense Senior Debt | $67.9K | $115.5K | $173.4K | $300.4K | $357.4K | $427.6K |
Balance Sheet
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|
| Stockholders Equity | $16.7M | $35.5M | $17.5M | $8.0M | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $3.7M | $13.3M | $9.4M | $23.8M | $17.1M | $2.1M |
| Retained Earnings Accumulated Deficit | -$98.9M | -$90.7M | -$70.7M | -$61.7M | ||
| Prepaid Expense And Other Assets | $2.0M | $1.3M | $3.7M | $2.8M | ||
| Liabilities Current | $10.8M | $7.1M | $31.0M | $41.9M | ||
| Liabilities And Stockholders Equity | $33.8M | $32.4M | $67.4M | $69.9M | ||
| Liabilities | $21.3M | $15.7M | $31.8M | $52.4M | ||
| Assets Current | $20.4M | $14.7M | $30.5M | $25.9M | ||
| Assets | $33.8M | $32.4M | $67.4M | $69.9M | ||
| Accrued Liabilities Current | $5.4M | $3.6M | $12.0M | $14.7M | ||
| Inventory And Sample Inventory Reserve | -$47.0K | -$68.9K | -$19.0K | -$200.3K | $1.8M | |
| Common Stock Value | $298.00 | $208.00 | $207.00 | $971.00 | ||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$9.6M | $3.9M | -$14.4M | $6.7M | $15.0M | |
| Property Plant And Equipment Net | $22.9K | $29.0K | $39.2K | $49.4K | $64.3K | |
| Other Liabilities Current | $78.2K | $493.3K | $537.2K | $260.8K | $221.8K | |
| Inventory Net | $1.3M | $1.6M | $1.8M | $519.6K | $760.5K | |
| Intangible Assets Net Excluding Goodwill | $3.2M | $9.0M | $12.2M | $25.3M | $32.2M | |
| Accounts Receivable Net Current | $416.1K | $2.2M | $2.1M | $2.5M | $5.2M | |
| Inventory Noncurrent | $4.2M | $5.1M | $11.0M | $11.1M | ||
| Other Liabilities Noncurrent | $75.2K | $137.7K | $262.7K | $405.0K | $600.9K | |
| Preferred Stock Dividends Income Statement Impact | $2.3M | $821.5K | ||||
| Accounts Payable Current | $1.7M | $1.8M | $4.6M | |||
| Preferred Stock Accretion Of Redemption Discount | $10.2M | $4.8M | ||||
| Notes Payable Current | $7.2M | $1.2M | $1.1M | |||
| Long Term Notes Payable | $6.9M | $8.4M | ||||
| Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | $1.3M | $556.7K | ||||
| Cash | $13.3M | $9.4M | $23.8M | $17.1M | ||
| Preferred Stock Redemption Including Cash Premium | $6.8M | $1.2M | ||||
| Temporary Equity Value Excluding Additional Paid In Capital | $1.0K | |||||
| Operating Lease Expense | $117.1K | $104.0K | $92.7K | |||
| Derivative Liabilities | $0.00 | $3.6M | $460.0K | $9.9M | ||
| Operating Lease Right Of Use Asset Amortization Expense | $112.5K | $132.2K | $117.1K | |||
| Accrual Of Series Convertible Preferred Stock Dividends | $1.3M | $556.7K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stockholders Equity | $3.4M | $4.4M | -$9.6M | -$7.5M | $3.1M | $8.1M | $9.8M | $12.1M | $6.9M | $12.9M | $15.4M | $20.7M | $34.2M | $35.7M | $17.8M | $19.5M | $20.9M | -$7.1M | -$3.8M | $1.9M |
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | $6.1M | $7.3M | $8.9M | $3.2M | $6.7M | $10.3M | $18.0M | $7.4M | $8.3M | $11.2M | $13.3M | $17.7M | $8.1M | $11.0M | $14.6M | $669.1K | $831.8K | $1.1M | ||
| Retained Earnings Accumulated Deficit | -$111.0M | -$110.0M | -$115.5M | -$113.2M | -$103.9M | -$101.7M | -$101.1M | -$99.2M | -$94.7M | -$92.1M | -$86.5M | -$72.7M | -$70.9M | -$62.5M | -$60.8M | -$58.7M | ||||
| Prepaid Expense And Other Assets | $63.2K | $75.3K | $53.4K | $885.00 | $1.8M | $1.9M | $2.1M | $987.1K | $1.0M | $1.1M | $1.7M | $1.9M | $3.5M | $2.7M | $2.7M | $2.6M | ||||
| Liabilities Current | $2.8M | $2.9M | $27.1M | $18.0M | $12.6M | $10.0M | $11.2M | $8.1M | $8.0M | $6.9M | $7.9M | $7.4M | $10.3M | $33.5M | $34.5M | $40.2M | ||||
| Liabilities And Stockholders Equity | $6.1M | $7.4M | $17.6M | $10.6M | $20.7M | $25.2M | $30.3M | $38.9M | $28.7M | $30.6M | $37.7M | $51.0M | $55.9M | $52.0M | $56.7M | $66.2M | ||||
| Liabilities | $2.8M | $2.9M | $27.2M | $18.1M | $17.6M | $16.0M | $19.6M | $31.9M | $15.8M | $15.1M | $17.0M | $16.8M | $20.1M | $34.2M | $37.2M | $45.2M | ||||
| Assets Current | $6.1M | $7.4M | $14.5M | $7.3M | $10.7M | $14.0M | $17.9M | $24.4M | $13.2M | $13.9M | $18.8M | $22.9M | $26.8M | $13.4M | $16.2M | $24.0M | ||||
| Assets | $6.1M | $7.4M | $17.6M | $10.6M | $20.7M | $25.2M | $30.3M | $38.9M | $28.7M | $30.6M | $37.7M | $51.0M | $55.9M | $52.0M | $56.7M | $66.2M | ||||
| Accrued Liabilities Current | $512.0K | $260.6K | $199.7K | $99.6K | $6.5M | $6.7M | $6.3M | $3.9M | $4.8M | $3.6M | $4.5M | $4.0M | $5.5M | $11.6M | $13.8M | $15.4M | ||||
| Inventory And Sample Inventory Reserve | $12.8K | $50.5K | $3.6K | $48.2K | $113.2K | |||||||||||||||
| Common Stock Value | $4.2K | $4.2K | $205.00 | $42.00 | $1.0K | $930.00 | $688.00 | $211.00 | $211.00 | $209.00 | $2.1K | $2.1K | $2.1K | $983.00 | $983.00 | $980.00 | ||||
| Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect | -$2.3M | -$1.1M | -$6.2M | -$2.6M | -$1.0M | |||||||||||||||
| Property Plant And Equipment Net | $18.8K | $23.8K | $26.4K | $31.5K | $34.1K | $36.6K | $41.7K | $44.3K | $46.8K | $52.0K | $54.5K | $57.1K | ||||||||
| Other Liabilities Current | $352.8K | $350.5K | $362.2K | $350.0K | $280.4K | $312.0K | $471.5K | $559.5K | $352.4K | $649.5K | $497.9K | $296.6K | ||||||||
| Inventory Net | $1.4M | $1.4M | $1.6M | $2.5M | $2.2M | $2.0M | $2.2M | $1.9M | $1.9M | $518.5K | $439.2K | $560.9K | ||||||||
| Intangible Assets Net Excluding Goodwill | $6.8M | $7.5M | $8.3M | $9.8M | $10.6M | $11.4M | $13.2M | $22.2M | $23.7M | $27.0M | $28.7M | $30.4M | ||||||||
| Accounts Receivable Net Current | $1.9M | $1.8M | $2.0M | $3.0M | $2.6M | $2.4M | $3.7M | $5.7M | $3.7M | $2.0M | $2.0M | $6.2M | ||||||||
| Inventory Noncurrent | $3.0M | $3.5M | $3.9M | $4.4M | $4.7M | $4.9M | $5.3M | $5.6M | $4.8M | $11.1M | $11.1M | $11.1M | ||||||||
| Other Liabilities Noncurrent | $91.8K | $107.8K | $123.0K | $151.4K | $183.3K | $223.6K | $300.2K | $336.1K | $371.1K | $437.7K | ||||||||||
| Preferred Stock Dividends Income Statement Impact | $231.2K | $218.2K | $275.2K | $1.1M | $216.8K | $595.5K | $339.2K | |||||||||||||
| Accounts Payable Current | $421.1K | $970.0K | $756.7K | $764.3K | $1.6M | $791.1K | $2.1M | $1.4M | $1.8M | $1.9M | $2.1M | |||||||||
| Preferred Stock Accretion Of Redemption Discount | $2.0M | $1.9M | $5.3M | $1.2M | ||||||||||||||||
| Notes Payable Current | $2.3M | $1.9M | $1.6M | $1.1M | $1.1M | $1.1M | $906.1K | $904.8K | $724.0K | |||||||||||
| Long Term Notes Payable | $4.9M | $5.7M | $6.5M | $7.2M | $7.6M | $8.0M | $8.8M | $9.1M | $9.5M | |||||||||||
| Adjustments To Additional Paid In Capital Dividends In Excess Of Retained Earnings | $218.2K | $275.2K | $236.8K | $153.8K | $601.1K | $249.7K | ||||||||||||||
| Cash | $6.1M | $7.3M | $8.9M | $1.7M | $13.3M | $17.7M | $8.1M | $11.0M | $14.6M | |||||||||||
| Preferred Stock Redemption Including Cash Premium | $232.1K | $901.8K | $5.5M | -$89.5K | ||||||||||||||||
| Temporary Equity Value Excluding Additional Paid In Capital | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | $1.0K | |||||||||||
| Operating Lease Expense | $31.6K | $28.0K | $25.2K | $22.2K | ||||||||||||||||
| Derivative Liabilities | $202.0K | $1.8M | $6.6M | $250.0K | $2.2M | $4.5M | ||||||||||||||
| Operating Lease Right Of Use Asset Amortization Expense | $35.7K | $31.6K | ||||||||||||||||||
| Accrual Of Series Convertible Preferred Stock Dividends | $275.2K | $601.1K |
Cash Flow Statement
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Operating Cash Flow * | -$2.6M | -$7.6M | -$12.8M | -$11.9M | -$15.3M |
| Depreciation Depletion And Amortization | $2.8M | $3.3M | $5.6M | $6.9M | $6.7M |
| Net Cash Provided By Used In Financing Activities | -$7.0M | $11.5M | -$1.6M | $18.6M | $30.3M |
| Increase Decrease In Prepaid Deferred Expense And Other Assets | -$1.6M | -$215.0K | -$1.6M | $724.8K | -$1.0M |
| Increase Decrease In Accrued Liabilities | $1.1M | $1.7M | -$1.8M | -$2.7M | -$6.2M |
| Increase Decrease In Accounts Payable | $615.7K | -$93.1K | -$2.8M | -$1.1M | $2.2M |
| Increase Decrease In Other Noncurrent Liabilities | -$62.4K | -$125.0K | -$142.3K | -$195.9K | -$148.6K |
| Increase Decrease In Other Current Liabilities | -$297.9K | $120.2K | $65.4K | -$31.3K | -$231.3K |
| Increase Decrease In Inventories | -$307.6K | -$273.6K | $835.3K | -$412.7K | -$728.3K |
| Increase Decrease In Accounts Receivable | -$1.8M | $144.1K | -$516.0K | -$2.5M | $2.8M |
| Employee Benefits And Share Based Compensation Noncash | $197.2K | $417.2K | $1.2M | $1.1M | |
| Proceeds From Repayments Of Notes Payable | -$765.3K | -$1.5M | -$1.6M | ||
| Net Cash Provided By Used In Investing Activities | -$24.6K | -$4.6K | |||
| Share Based Compensation | $1.1M |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow * | -$1.7M | -$1.1M | -$748.4K | -$5.3M | -$446.6K | -$2.4M | ||||||||||
| Depreciation Depletion And Amortization | $739.4K | $717.8K | $717.8K | $826.8K | $826.8K | $826.8K | $1.6M | $1.6M | $1.6M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | $1.7M | |
| Net Cash Provided By Used In Financing Activities | $8.7M | -$1.1M | -$357.8K | -$900.0K | -$2.1M | $1.4M | ||||||||||
| Increase Decrease In Prepaid Deferred Expense And Other Assets | $52.5K | $41.0K | -$180.2K | -$237.5K | -$172.1K | -$1.3M | ||||||||||
| Increase Decrease In Accrued Liabilities | $100.1K | $105.6K | -$25.7K | $74.9K | $698.5K | $531.1K | ||||||||||
| Increase Decrease In Accounts Payable | -$211.6K | -$48.1K | $52.0K | -$857.6K | -$333.3K | $1.4M | ||||||||||
| Increase Decrease In Other Noncurrent Liabilities | -$14.6K | -$39.1K | -$34.0K | -$100.4K | -$25.0K | |||||||||||
| Increase Decrease In Other Current Liabilities | -$13.8K | $35.1K | $162.0K | $75.0K | $115.2K | |||||||||||
| Increase Decrease In Inventories | -$40.6K | $55.1K | $1.4M | -$194.0K | -$225.5K | |||||||||||
| Increase Decrease In Accounts Receivable | -$320.3K | $325.6K | $1.2M | $1.0M | $1.5M | |||||||||||
| Employee Benefits And Share Based Compensation Noncash | $80.0K | $180.4K | $130.3K | |||||||||||||
| Proceeds From Repayments Of Notes Payable | -$357.8K | -$900.0K | ||||||||||||||
| Net Cash Provided By Used In Investing Activities | -$4.4K | |||||||||||||||
| Share Based Compensation | $130.3K | $302.3K | $355.8K | $590.5K | $347.2K |
Per-Share & Share Counts
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Diluted EPS * | -$3.34 | -$6.35 | -$9.68 | -$8.25 | -$3.85 |
| Weighted Average Number Of Shares Outstanding Basic | 8.0M | 2.2M | 2.1M | 1.1M | 5.3M |
| Weighted Average Number Of Diluted Shares Outstanding | 8.0M | 2.2M | 2.1M | 1.1M | 5.3M |
| Earnings Per Share Basic | $-3.34 | $-6.35 | $-9.68 | $-8.25 | $-3.85 |
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | |
| Common Stock Shares Outstanding | 3.0M | 2.1M | 2.1M | 9.7M | |
| Common Stock Shares Issued | 3.0M | 2.1M | 2.1M | 9.7M | |
| Common Stock Shares Authorized | 250.0M | 150.0M | 150.0M | 150.0M | |
| Temporary Equity Shares Outstanding | 0.00 | ||||
| Temporary Equity Shares Issued | 0.00 | ||||
| Temporary Equity Shares Authorized | 0.00 | ||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q3 2020 | Q2 2020 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Diluted EPS * | -$0.03 | -$1.29 | -$9.37 | -$16.65 | -$9.25 | -$42.19 | -$2.85 | -$1.20 | -$0.66 | -$6.69 | -$0.88 | -$0.08 | -$0.17 | -$0.22 | $0.31 | -$0.96 | -$1.68 | -$1.23 | ||
| Weighted Average Number Of Shares Outstanding Basic | 42.3M | 25.9M | 1.2M | 393.2K | 295.5K | 190.3K | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | 9.8M | 9.8M | 9.8M | 3.4M | 3.4M | 4.9M | ||
| Weighted Average Number Of Diluted Shares Outstanding | 42.3M | 25.9M | 1.2M | 393.2K | 295.5K | 190.3K | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | 2.1M | 9.8M | 9.8M | 9.8M | 3.4M | 3.4M | 4.9M | ||
| Earnings Per Share Basic | $-0.03 | $-1.29 | $-9.37 | $-16.65 | $-9.25 | $-42.19 | $-2.85 | $-1.20 | $-0.66 | $-6.69 | $-0.88 | $-0.08 | $-0.17 | $-0.22 | $0.31 | $-0.96 | ||||
| Common Stock Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | ||||
| Common Stock Shares Outstanding | 42.3M | 42.3M | 2.1M | 421.1K | 10.0M | 9.3M | 6.9M | 2.1M | 2.1M | 2.1M | 20.7M | 20.7M | 20.7M | 9.8M | 9.8M | 9.8M | ||||
| Common Stock Shares Issued | 42.3M | 42.3M | 2.1M | 421.1K | 10.0M | 9.3M | 6.9M | 2.1M | 2.1M | 2.1M | 20.7M | 20.7M | 20.7M | 9.8M | 9.8M | 9.8M | ||||
| Common Stock Shares Authorized | 7.00B | 7.00B | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 250.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | 150.0M | ||||
| Temporary Equity Shares Outstanding | 0.00 | 0.00 | 0.00 | 0.00 | 1.0K | 4.0K | 5.7K | 10.0K | 13.8K | |||||||||||
| Temporary Equity Shares Issued | 0.00 | 0.00 | 0.00 | 0.00 | 1.0K | 4.0K | 5.7K | 10.0K | 13.8K | |||||||||||
| Temporary Equity Shares Authorized | 15.0K | 15.0K | 15.0K | 15.0K | 15.0K | 15.0K | 15.0K | 15.0K | 15.0K | |||||||||||
| Temporary Equity Par Or Stated Value Per Share | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
Other Metrics
Annual (10-K / 20-F)
| Metric \ Fiscal Year | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|
| Derivative Gain Loss On Derivative Net | $3.6M | $2.6M | $460.0K | $9.4M | -$1.7M |
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $1.2M | $1.1M | |||
| Additional Paid In Capital | $111.0M | $107.4M | $106.2M | $79.2M | |
| Interest Paid Net | $234.7K | $536.1K | $596.0K | $421.8K | $1.2M |
| Provision For Doubtful Accounts | -$8.6K | $28.2K | -$170.8K | $148.9K | $202.5K |
Quarterly (10-Q, single quarters)
| Metric \ Quarter | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q3 2023 | Q2 2023 | Q1 2023 | Q3 2022 | Q2 2022 | Q1 2022 | Q3 2021 | Q2 2021 | Q1 2021 | Q1 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Derivative Gain Loss On Derivative Net | $202.0K | $1.6M | $1.7M | -$430.0K | $460.0K | $2.0M | $2.3M | $5.4M | |||||||||
| Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | $16.8K | $180.4K | $30.8K | $43.3K | $130.3K | $308.1K | $302.3K | $355.8K | $17.8M | $590.5K | $347.2K | ||||||
| Additional Paid In Capital | $114.3M | $114.5M | $105.9M | $105.7M | $107.0M | $109.8M | $110.8M | $106.1M | $107.6M | $107.6M | $107.2M | $106.9M | $106.6M | $80.3M | $80.3M | $79.6M | |
| Interest Paid Net | $142.2K | $176.7K | $372.1K | ||||||||||||||
| Provision For Doubtful Accounts | -$51.1K | $36.2K | -$115.4K | $3.0K |
Most recent annual filing with the SEC: March 31, 2025
Data sourced from SEC EDGAR public filings as of August 5, 2026.